We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$463M
AUM Growth
+$326M
Cap. Flow
+$324M
Cap. Flow %
69.94%
Top 10 Hldgs %
8.1%
Holding
694
New
390
Increased
110
Reduced
28
Closed
165

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$5.03M
2
NKE icon
Nike
NKE
+$4.85M
3
WMT icon
Walmart Inc
WMT
+$4.79M
4
TRU icon
TransUnion
TRU
+$3.45M
5
ODFL icon
Old Dominion Freight Line
ODFL
+$3.4M

Top Sells

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$2.99M
2
LHX icon
L3Harris
LHX
+$2.1M
3
XLNX
Xilinx Inc
XLNX
+$1.93M
4
CLGX
Corelogic, Inc.
CLGX
+$1.83M
5
BABA icon
Alibaba
BABA
+$1.51M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.69%
2 Technology 15.79%
3 Healthcare 14.21%
4 Industrials 12.25%
5 Financials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLWS icon
126
1-800-Flowers.com
FLWS
$269M
$1.19M 0.26%
+47,500
New +$1.26M
JBL icon
127
Jabil
JBL
$33.4B
$1.18M 0.25%
34,400
+25,000
+266% +$836K
DOMO icon
128
Domo
DOMO
$184M
$1.18M 0.25%
30,700
+19,800
+182% +$714K
VAR
129
DELISTED
Varian Medical Systems, Inc.
VAR
$1.17M 0.25%
+6,773
New +$1.06M
PPLI
130
People Inc
PPLI
$3.13B
$1.16M 0.25%
+17,772
New +$1.22M
GOCO
131
DELISTED
GoHealth
GOCO
$1.15M 0.25%
+5,907
New +$1.42M
GILD icon
132
Gilead Sciences
GILD
$163B
$1.15M 0.25%
+18,200
New +$1.26M
KDP icon
133
Keurig Dr Pepper
KDP
$42.1B
$1.15M 0.25%
41,900
+26,700
+176% +$782K
KPTI icon
134
Karyopharm Therapeutics
KPTI
$44.6M
$1.13M 0.24%
+5,173
New +$1.27M
F icon
135
Ford
F
$57.5B
$1.12M 0.24%
+168,773
New +$1.14M
MAR icon
136
Marriott International
MAR
$90.4B
$1.12M 0.24%
+12,145
New +$1.15M
MNRO icon
137
Monro
MNRO
$399M
$1.12M 0.24%
+27,641
New +$1.41M
DISH
138
DELISTED
DISH Network Corp.
DISH
$1.12M 0.24%
+38,624
New +$1.28M
VLO icon
139
Valero Energy
VLO
$88.5B
$1.12M 0.24%
+25,817
New +$1.35M
NIO icon
140
NIO
NIO
$12.1B
$1.11M 0.24%
52,230
+18,630
+55% +$287K
INMD icon
141
InMode
INMD
$882M
$1.1M 0.24%
+61,000
New +$1M
KSU
142
DELISTED
Kansas City Southern
KSU
$1.1M 0.24%
+6,100
New +$1.06M
JEF icon
143
Jefferies Financial Group
JEF
$12.8B
$1.1M 0.24%
+63,893
New +$1.05M
RS icon
144
Reliance Steel & Aluminium
RS
$20.9B
$1.1M 0.24%
+10,746
New +$1.09M
UAL icon
145
United Airlines
UAL
$41.7B
$1.09M 0.24%
+31,394
New +$1.09M
WW
146
DELISTED
WW International
WW
$1.09M 0.24%
+57,746
New +$1.36M
MNST icon
147
Monster Beverage
MNST
$91.5B
$1.07M 0.23%
26,800
+20,200
+306% +$798K
GIS icon
148
General Mills
GIS
$19.2B
$1.07M 0.23%
+17,400
New +$1.09M
EFX icon
149
Equifax
EFX
$20.5B
$1.07M 0.23%
+6,800
New +$1.11M
ALL icon
150
Allstate
ALL
$67.6B
$1.06M 0.23%
+11,300
New +$1.05M

Similar funds

Seven Eight Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Seven Eight Capital held 694 positions worth $463M, up 239% from $137M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Seven Eight Capital deployed $324M of net new capital in Q3 2020, opening 390 new positions and adding to 110 existing holdings. Its largest new stake was Nike: 45,200 shares worth $5.67M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Xilinx Inc, an estimated $1.93M trimmed.

  • Seven Eight Capital's largest Q3 2020 buy was Nike: 45,200 shares worth $5.67M.
  • Seven Eight Capital added most to Cigna in Q3 2020, an estimated $5.03M increase.
  • Seven Eight Capital's biggest Q3 2020 reduction was Xilinx Inc, cutting an estimated $1.93M.
  • Seven Eight Capital fully exited Conagra Brands in Q3 2020, selling an estimated $2.99M.
  • Seven Eight Capital's ten largest holdings make up 8.1% of its $463M portfolio in Q3 2020.
  • Seven Eight Capital opened 390 new positions and closed 165 in Q3 2020.
  • Seven Eight Capital's portfolio value rose 239% quarter-over-quarter to $463M.

Based on Seven Eight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.